Erratum: Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections (Clinical Infectious Diseases (2012) 55 (1495-502) DOI: 10.1093/cid/cis758);Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections

Clinical Infectious Diseases

Volumn 55, Issue 11, 2012, Pages 1495-1502

  Cohen Wolkowiez, Michael ^a,b   Poindexter, Brenda ^c   Bidegain, Margarita ^a   Weitkamp, Joern Hendrik ^d   Schelonka, Robert L ^e   Randolph, David A ^f   Ward, Robert M ^g   Wade, Kelly ^h   Valencia, Gloria ⁱ   Burchfield, David ^j   Arrieta, Antonio ^k   Mehta, Varsha ^l   Walsh, Michele ^m   Kantak, Anand ⁿ   Rasmussen, Maynard ^o   Sullivan, Janice E ^p   Finer, Neil ^q   Rich, Wade ^q   Brozanski, Beverly S ^r   Van Den Anker, John ^s   Blumer, Jeffrey ^t   Laughon, Matthew ^u   Watt, Kevin M ^a   Kearns, Gregory L ^v,w   Capparelli, Edmund V ^x   Martz, Karen ^y   Berezny, Katherine ^b   Benjamin, Daniel K ^a,b   Smith, P Brian ^a,b   more..

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c INDIANA UNIVERSITY   (United States)

^d MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f University of Alabama at Birmingham   (United States)

^g UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^h CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

ⁱ SUNY DOWNSTATE MEDICAL CENTER   (United States)

^j UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^k CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^l UNIVERSITY OF MICHIGAN   (United States)

^m UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

ⁿ AKRON CHILDREN'S HOSPITAL   (United States)

^o SHARP HEALTHCARE   (United States)

^p KOSAIR CHILDREN'S HOSPITAL   (United States)

^q UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^r CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^s GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^t MEDICAL COLLEGE OF OHIO   (United States)

^u UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^v UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^w CHILDREN S MERCY HOSPITAL   (United States)

^x UNIVERSITY OF CALIFORNIA   (United States)

^y EMMES CORPORATION   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MEROPENEM;

ABDOMINAL INFECTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATELECTASIS; BACTERIUM CULTURE; CHILD HOSPITALIZATION; COHORT ANALYSIS; CRITICALLY ILL PATIENT; DRUG SAFETY; FEMALE; FUNGEMIA; HUMAN; HYPERGLYCEMIA; HYPOKALEMIA; HYPOTENSION; INFANT; INFANT DISEASE; INFANT MORTALITY; MAJOR CLINICAL STUDY; MALE; NEWBORN INTENSIVE CARE; OPEN STUDY; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; SEIZURE; SIDE EFFECT; SMALL INTESTINE PERFORATION; VOMITING;

EID: 84869070247     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis997     Document Type: Erratum

References (17)

1. Stevenson DK, Wright LL, Lemons JA, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. Am J Obstet Gynecol 1998; 179(6 Pt 1):1632-9.
2. Vohr BR, Wright LL, Dusick AM, et al. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics 2000; 105:1216-26.
3. Yeh TC, Chang JH, Kao HA, Hsu CH, Hung HY, Peng CC. Necrotizing enterocolitis in infants: clinical outcome and influence on growth and neurodevelopment. J Formos Med Assoc 2004; 103:761-6.
4. Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010; 50:133-64.
5. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011; 364:255-64.
6. Pfaller MA, Jones RN. A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide. Diagn Microbiol Infect Dis 1997; 28:157-63.
7. Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics 2006; 117:1979-87.
8. Smith PB, Cohen-Wolkowiez M, Castro LM, et al. Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections. Pediatr Infect Dis J 2011; 30:844-9.
9. Lowe MN, Lamb HM. Meropenem: an updated review of its use in the management of intra-abdominal infections. Drugs 2000; 60: 619-46.
10. Seifert H, Dalhoff A. German multicentre survey of the antibiotic susceptibility of Bacteroides fragilis group and Prevotella species isolated from intra-abdominal infections: results from the PRISMA study. J Antimicrob Chemother 2010; 65:2405-10.
11. Bradley JS, Faulkner KL, Klaugman KP. Effectiveness, safety, and tolerability of meropenem as empiric antibiotic therapy in hospitalized pediatric patients. Pediatr Infect Dis J 1996; 15:749-57.
12. Schuler D. Safety and effectiveness of meropenem in hospitalised children: randomised comparison with cefotaxime, alone and combined with metronidazole or amikacin. Meropenem Paediatric Study Group. J Antimicrob Chemother 1995; 36(suppl A):99-108.
13. Odio CM, Puig JR, Feris JM, et al. Prospective, randomized, investigator-blinded study of the effectiveness and safety of meropenem vs cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group. Pediatr Infect Dis J 1999; 18:581-90.
14. Sheth RD, Hobbs GR, Mullett M. Neonatal seizures: incidence, onset, and etiology by gestational age. J Perinatol 1999; 19:40-3.
15. Linden P. Safety profile of meropenem: an updated review of over 6000 patients treated with meropenem. Drug Saf 2007; 30:657-68.
16. Jin C, Jung I, Ku HJ, et al. Low convulsive activity of a new carbapenem antibiotic, DK-35C, as compared with existing congeners. Toxicology 1999; 138:59-67.
17. Kubota A, Yonekura T, Hoki M, et al. Total parenteral nutritionassociated intrahepatic cholestasis in infants: 25 years' experience. J Pediatr Surg 2000; 35:1049-51.